Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-04-11 @ 6:06 AM
Study NCT ID:
NCT00392392
Status:
COMPLETED
Last Update Posted:
2013-09-20
First Post:
2006-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-25
First Submit QC Date:
None
Study First Post Date:
2006-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-11
Results First Submit QC Date:
None
Results First Post Date:
2013-02-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-17
Last Update Post Date:
2013-09-20
Last Update Post Date Type:
ESTIMATED